Dr. Schulz presented on the use of emerging biomarkers to aid in the earlier diagnosis of Alzheimer’s disease. This 30-minute presentation discusses the potential ways in which biomarkers can be assessed before the symptoms of cognitive impairment become apparent. Dr. Paul E. Shulz is the Rick McCord Professor in Neurology, the Umphrey Family Professor of Neurodegenerative Disorders, the Director of the Memory Disorders and Dementia Clinic, and the Director of the Neuropsychiatry and Behavioral Neurology Fellowship at the McGovern Medical School of UT Health Houston.
Disclosure: The speaker received honoraria from Biogen for participation in this virtual education theater.
Disclaimer: All of the information discussed is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.